A multiplex qPCR kit for the detection of Candida auris, Macrolide (MefA) & Class A beta-lactamase (CTX-M) Resistance

Macrolide (mefA) resistance is a major concern in the healthcare sector, especially in the treatment of bacterial infections. The presence of this resistance marker can lead to treatment failure and the spread of drug-resistant bacteria. Candida auris is an emerging multidrug-resistant fungal pathogen that can cause severe infections in healthcare settings, with symptoms ranging from mild to severe, including invasive bloodstream infections.

YouSeq's qPCR kit to detect Macrolide (mefA) resistance and Candida auris allows for rapid and accurate identification of these pathogens, enabling healthcare providers to make informed treatment decisions and prevent the spread of drug resistance. Early detection of these targets is crucial in preventing treatment failure and reducing the impact of these pathogens on patient outcomes and healthcare costs.

For Research Use Only. Not intended for diagnostic use.